Related Experiment Video
Updated: Feb 20, 2026

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
Modified Shenqi compound alleviated constipation and inflammation in diabetic mice by regulating the miR-23a-3p/Nrf2
Xinghua Zhou1, Gehang You2, Liangliang Zhang1
1Department of Anorectal Diseases, Hospital of Chengdu University of Traditional Chinese Medicine, No. 39, 12 Qiao Road, Jinniu District, Chengdu, 610075, China.
None:
Constipation is a prevalent gastrointestinal complication in patients with diabetes mellitus (DM), characterized by infrequent bowel movements and difficulty in defecation. Modified Shenqi Compound (MSQC), a traditional Chinese medicine (TCM) formulation, has demonstrated therapeutic efficacy against DM; however, its mechanisms in alleviating diabetic constipation remain unclear. This study investigates the effects and underlying mechanisms of MSQC in a mouse model of diabetic constipation. Diabetic mice with constipation were treated with MSQC, and various parameters including constipation symptoms, intestinal mucosal damage, inflammatory response, gut microbiota composition, and oxidative stress were evaluated. Additionally, miR-23a-3p antagomir was used to investigate the role of the miR-23a-3p/Nrf2 axis in mediating the effects of MSQC. The results showed that MSQC administration significantly ameliorated constipation symptoms, attenuated intestinal mucosal damage, and reduced inflammatory responses. Moreover, MSQC modulated the gut microbiota profile, notably decreasing the abundance of Cryptobacteroides while increasing that of Faecalibaculum, Vagococcus_B. In addition, MSQC inhibited intestinal oxidative stress via upregulating miR-23a-3p, which in turn promoted the expression of its downstream target, Nrf2. Crucially, the co-administration of a miR-23a-3p antagomir reversed the therapeutic benefits of MSQC, counteracting its improvements on constipation symptoms, intestinal mucosal injury, and inflammation. In conclusion, MSQC effectively alleviates diabetic constipation through a multi-targeted mechanism involving the activation of the miR-23a-3p/Nrf2 antioxidant pathway, reinforcement of the intestinal barrier, suppression of inflammation, and restoration of gut microbial homeostasis. Our findings provide a mechanistic basis for the clinical application of MSQC in treating diabetic constipation.
More Related Videos
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025